Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Interleukin-2 (IL-2)]

T Taguchi1

  • 1Osaka University.

Gan to Kagaku Ryoho. Cancer & Chemotherapy
|April 1, 1994
PubMed
Summary
This summary is machine-generated.

Interleukin-2 (IL-2), a T-cell growth factor, stimulates immune cell proliferation. Research explored its therapeutic potential in cancer and immunodeficiencies, leading to clinical trials.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[The effect of CPT-11 in combination with interferon-alpha against human colon carcinoma heterotransplanted in nude mice: preliminary report].

Nihon Geka Gakkai zasshi·1992
Same author

[Correlation of DBA lectin binding and malignancy in breast cancers: preliminary report].

Nihon Geka Gakkai zasshi·1992
Same author

Pokeweed mitogen induces p55 interleukin-2 receptor expression on human monocytes and its effect on interleukin-2 activated monocyte cytotoxicity.

Immunological investigations·1992
Same author

[Athyreotic congenital hypothyroidism in two sisters].

Nihon Naibunpi Gakkai zasshi·1992
Same author

Immunological identification of a Cl- channel protein in electric organs of Narke japonica.

Biochemical and biophysical research communications·1992
Same author

DNA synthesis and related enzymes altered in compensatory lung growth in rats.

Scandinavian journal of clinical and laboratory investigation·1992
Same journal

[A Case of Pulmonary Epithelioid Hemangioendothelioma Associated with Multiple Cancers].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[Long-Term Survival in Three Cases with Pulmonary Metastases from Colorectal Cancer Given Low-Dose S-1 Under a Regimen Combining a Carbohydrate-Restricted Ketogenic Diet, Metformin, Vitamin D, Eicosapentaenoic Acid, and Other Complementary Therapies].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[Preventive Effect of Saline Eye Wash for Eye Symptoms Due to High-Dose and Intermediate-Dose Cytarabine Therapy].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[Examination of Factors Affecting the Efficacy of Naldemedine Tosilate Tablets for Opioid-Induced Constipation].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[Recent Advances in the Treatment of HER2-Altered Solid Tumors].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[BRAF-Mutant Solid Tumor].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
See all related articles

Area of Science:

  • Immunology
  • Molecular Biology
  • Biochemistry

Context:

  • Interleukin-2 (IL-2), initially termed "T-cell growth factor," is a key lymphokine regulating T-cell proliferation.
  • Discovered in 1976, IL-2 is primarily secreted by T-helper cells and modulates immune cell function.
  • The human IL-2 gene was isolated and sequenced in the early 1980s, revealing a mature protein of 133 amino acids.

Purpose:

  • To review the discovery and characterization of Interleukin-2 (IL-2).
  • To explore the immunopotentiating activities and therapeutic rationale for IL-2 in malignancy and immunodeficiencies.
  • To summarize clinical trial findings of IL-2 in cancer patients.

Summary:

  • IL-2's role in T-cell proliferation and immune modulation is well-established.

Related Experiment Videos

  • Preclinical studies demonstrated IL-2's efficacy in animal tumor models, justifying clinical investigations.
  • The IL-2 receptor structure, comprising alpha, beta, and gamma chains, has been elucidated.

    • Impact:

    • IL-2's immunomodulatory properties have driven research into its clinical applications.
    • Clinical trials have investigated IL-2 as a therapeutic agent for advanced cancers and immunodeficiencies.
    • Understanding IL-2 and its receptor complex is crucial for developing novel immunotherapies.